Clinical Trial Update: HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer. [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update compares high-dose-rate brachytherapy and low-dose-rate brachytherapy as monotherapy for localized prostate cancer. The study is in P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma

Drugs mentioned

• HDR brachytherapy
• LDR brachytherapy

Snippet

Sponsor: National Institute of Oncology, Hungary | Conditions: Adenocarcinoma of Prostate | Phase 2, Phase 3 | Status: UNKNOWN